Search Result "spindle assembly checkpoint"
Targeting the Spindle Assembly Checkpoint for Breast Cancer Treatment
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 4 Year: 2015 Page: 272-281
Author(s): Sandra Marques,Joana Fonseca,Patricia M.A. Silva,Hassan Bousbaa
Assessment of the Mitotic Spindle Assembly Checkpoint (SAC) as the Target of Anticancer Therapies
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 2 Year: 2009 Page: 131-141
Author(s): Victor M. Bolanos-Garcia
Spindle Assembly Checkpoint (SAC): More New Targets for Anti-Cancer Drug Therapies
Ebook: Advances in Cancer Drug Targets
Volume: 2 Year: 2014
Author(s): Maria Kapanidou,Victor M. Bolanos-Garcia
Doi: 10.2174/9781608059386114020004
Targeting the Kinetochore in Cancer Therapy: The Ndc80/Hec1 Complex
Journal: Current Drug Therapy
Volume: 5 Issue: 1 Year: 2010 Page: 29-35
Author(s): Elena Diaz-Rodriguez
The Mad2-Binding Protein p31comet as a Potential Target for Human Cancer Therapy
Journal: Current Cancer Drug Targets
Volume: 21 Issue: 5 Year: 2021 Page: 401-415
Author(s): Ana C. Henriques,PatrÃcia M. A. Silva,Bruno Sarmento,Hassan Bousbaa
Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1504-1519
Author(s): Nicholas D`Arcy,Brian Gabrielli
Genes that Modulate the Sensitivity for Anti-Microtubule Drug-Mediated Chemotherapy
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 6 Year: 2010 Page: 623-633
Author(s): H.Y. Yamada, C.V. Rao
Identification of Potential Mps1 Inhibitors Through Multiple Pharmacophore- based Virtual Screening and Molecular Docking
Journal: Letters in Drug Design & Discovery
Volume: 12 Issue: 7 Year: 2015 Page: 558-573
Author(s): Xiaoli Li,Lu Zhou,Yahui Tian,Suwen Zhou
Discovery of Allosteric Inhibitors of Kinesin Spindle Protein (KSP) for the Treatment of Taxane-Refractory Cancer: MK-0731 and Analogs
Ebook: Advances in Anticancer Agents in Medicinal Chemistry
Volume: 1 Year: 2013
Author(s): Christopher D. Cox,Robert M. Garbaccio
Doi: 10.2174/9781608054930113010010
Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 186-191
Author(s): Suzanne Leijen, Jos H. Beijnen, Jan H.M. Schellens